| Identifier | Protein names | Gene names | Cross reference refseq | Length | Species |
| Q6EXB0 | MHC class I antigen; | HLA-A; | NULL | 365 | human |
| G5EA42 | Tropomodulin 2 (Neuronal), isoform CRA_a; Tropomodulin-2; | TMOD2; | NULL | 307 | human |
| H0YM44 | N-acetylgalactosamine kinase; | GALK2; | NULL | 49 | human |
| H9NIM5 | Regulator of G-protein signaling 20 variant 2; Regulator of G-protein signalling 20, isoform CRA_e; | RGS20; | NP_003693.2; | 241 | human |
| B7TNT0 | Cytochrome b; | CYTB; | NULL | 378 | human |
| D3DPZ6 | MutY homolog (E. coli), isoform CRA_f; | MUTYH; | NP_001280121.1;NP_001280125.1; | 429 | human |
| I6LJZ7 | BCL2L12 protein isoform 5; Bcl-2-like protein 12; | BCL2L12; | NP_001269448.1; | 269 | human |
| G3XAL9 | Solute carrier family 12 (Sodium/potassium/chloride transporters), member 2, isoform CRA_a; Solute carrier family 12 member 2; | SLC12A2; | NULL | 1150 | human |
| Q6ZQU4 | Chromosome 20 open reading frame 151, isoform CRA_a; cDNA FLJ46885 fis, clone UTERU3016274; | C20orf151; | NULL | 410 | human |
| H0YNM9 | Interferon regulatory factor 9; | IRF9; | NULL | 50 | human |
| B2Y8X6 | NADH-ubiquinone oxidoreductase chain 4; EC 1.6.5.3; | ND4; | NULL | 459 | human |
| D3DQQ7 | Low density lipoprotein receptor-related protein 4, isoform CRA_a; | LRP4; | NULL | 1678 | human |
| A6YZJ2 | NADH-ubiquinone oxidoreductase chain 6; EC 1.6.5.3; | ND6; | NULL | 174 | human |
| B2XQL2 | NADH-ubiquinone oxidoreductase chain 5; EC 1.6.5.3; | ND5; | NULL | 603 | human |
| A6Z7K1 | ATP synthase protein 8; | ATP8; | NULL | 68 | human |
| Q7Z759 | CCT8 protein; Chaperonin containing TCP1, subunit 8 (Theta), isoform CRA_c; | CCT8; | NP_001269837.1; | 497 | human |
| Q6KEC3 | Cystic fibrosis transmembrane conductance regulator; Fragment; | CFTR; | NULL | 83 | human |
| Q5Q736 | NADH-ubiquinone oxidoreductase chain 1; EC 1.6.5.3; Fragment; | ND1; | NULL | 130 | human |
| Q85KX6 | Cytochrome b; | cytb; CYTB; | NULL | 378 | human |
| F1B6V0 | NADH-ubiquinone oxidoreductase chain 5; EC 1.6.5.3; | ND5; | NULL | 603 | human |
UrgentMab™: Thinking is cheap. Test your ideas, fast and furious. |
 |
|
Custom monoclonal antibody in one month. As low as $200-300 per antigen. |
|
A product of Absolution |
|
SEAL™: Today's out-of-reach protein targets made accessible. |
|
|
Same budget, 5-10 times more antibodying SEAL your protein. Successes too. |
|
A product of Absolution |
|
PETAL™: Fast and high throughput antibody discover platform. |
 |
|
Deliver customized antibody in two weeks at price of category antibody Proteome-scale antibody discovery for any organism or proteome Biomarker discovery for biological processes or human diseases |
|
A product of Absolution |
|
AbFocus™: Target all the modification sites of your protein, affordably. |
|
|
Test them with a panel of AbFocus antibodies It is so affordable that you can focus on testing, not guessing |
|
A product of Absolution |
Mabome™: Catch the antibody gold rush.? Lead the next omics revolution. |
|
|
First-ever antibody proteomics technology. High quality monoclonal antibodies for your favorite proteome. As low as $19/monoclonal antibody |
|
A product of Absolution |
AbTarget™: Performing antibody for your proteome.? Guaranteed |
|
|
Fast, efficient monoclonal antibody development for proteins in a proteome Pay for successful antibodies only |
|
A product of Absolution |
AbProfile™: Discover an array of unbiased differences.? Proteome-scale |
|
|
50,000 monoclonal antibodies on an array.100 times more content. Differential profiling thousands of cell surface receptorsand plasma proteins |
|
A product of Absolution |
|
SMAL™:?All big things have a SMAL beginning. |
|
|
High success rate for mAb generation Deliver a panel of high affinity mAbs Flexible and optional fee structure for minimizing risks |
|
A product of Absolution |
AbX™: X=anything.? Find your antibody within |
|
|
currently 7species.?200,000 mAbs.70,000 proteins 3 new organisms are being AbXed/day Pre-made anti-peptide mAbs against all proteins in nature. |
|
A product of AbStore |
AbStop™: The last stop of antibody development. The most successful stop. |
|
|
Pre-designed antibody packages against high value targets The most aggressive and comprehensive protein targeting Best for diagnostics and therapeutic antibody development |
|
A product of AbStore |